Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 randomised, placebo-controlled trial in North America and Europe
1. 系统已在2026-06-11 14:26:01对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/s2215-0366(21)00386-2
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2215036621003862
其他信息:
出版社: Elsevier BV
作者: Dragana Bugarski-Kirola; Celso Arango; Maurizio Fava; Henry Nasrallah; I-Yuan Liu; Brandon Abbs; Srdjan Stankovic

